Final guidance for drugmakers on gathering comprehensive and representative input from patients is now available from the US Food and Drug Administration (FDA). The guidance outlines what constitutes ...
Patient-focused drug development has caught the attention of both US legislators and regulators in recent years, with the former instructing the latter to make it a part of the US Food and Drug ...
As advocacy efforts bolster the need for patient-focused drug development, amidst regulatory encouragement, the value of listening to patients is being realised in a more actionable manner. “You can ...
Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes. Patient experience data are critical to ...
TUCSON, Ariz., March 10, 2026– Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of Neurology that offers critical longitudinal insights into how symptoms and ...
Patient engagement has matured from aspiration to necessity as precision medicine moves from laboratory concept to bedside. Cutting-edge therapies increasingly target narrowly defined genetic or ...
Alopecia areata affects 8.3 million people globally, significantly impacting quality of life. PROMs are essential for integrating patient perspectives into drug development and evaluating treatment ...
Ametris (formerly ActiGraph) has launched its second Digital Endpoint Collaboration Outcome Development (DECODE) working group for the purpose of enhancing drug development for obesity. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results